Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Long Term Outcomes after Complex PCI According to Operator Experience and Use of IVUS

The use of intravascular ultrasound (IVUS) to guide percutaneous coronary interventions (PCI) has been shown to reduce the risk of major adverse cardiovascular events (MACE) across controlled randomized studies, registries and meta-analysis. Current guidelines recommend the use of IVUS in left main disease and complex lesions. 

Resultados a largo plazo luego de una ATC compleja según la experiencia del operador y la utilización de IVUS

As the prevalence of complex PCI increases over time, together with operator experience, several studies have shown that high volume centers or centers with experienced operators are associated with a remarkable reduction in future MACE risk, unlike low volume centers or those with less experienced operators. 

The aim of this retrospective, observational study was to assess the link between operator experience and lesion complexity, as well as the correlation between operator experience and long term clinical outcomes. In addition, we looked into the interaction between operator experience and the effects of the use of IVUS in long term clinical outcomes. 

Primary end point was the combination of cardiovascular mortality or target vessel myocardial infarction (TVMI) at 10 years. Secondary end point included cardiac mortality rate, AMI, TVMI, definite or probable stent thrombosis and ischemia driven target lesion revascularization (TLR) at 10 years.

In patients with complex heart disease, 63.4% underwent PCI by experienced operators, while 36.6% were treated by less experienced operators. 

More experienced operators used IVUS more frequently for complex lesions, and presented a higher annual volume of PCI vs. their less experienced counterparts. Also, experienced operators exhibited higher SYNTAX scores, higher number of lesions, longer lesions, and more left main compromise. Patients undergoing IVUS guided PCI tended to be younger and present fewer cardiovascular risk factors, as well as fewer prior AMI and stroke. 

Read also: bRight: Impact and Safety of the TriClip Device in a Real-World Cohort.

As regards outcomes, experienced operators showed lower risk of cardiac mortality or TVMI vs. less experienced ones. (HR: 0.779; CI 95%: 0.663-0.915; P = 0.002). The use of IVUS was significantly associated with reduced risk of cardiac mortality and TVMI vs. the group submitted to angiography guided PCI, both for less experienced operators (23.5% vs 11.4%; HR: 0.477; CI 95%: 0.337-0.673; P < 0.001) and the more experienced ones (18.0% vs 13.5%; HR: 0.747; CI 95%: 0.559-0.998; P = 0.048). There was a significant interaction between the use of IVUS and operator expertise when it came to cardiac mortality or TVMI risk (P = 0.037).

Conclusion

In conclusion, among patients with complex coronary PCI, IVUS guided PCI was associated with better outcomes at long term vs. angiography guided PCI, regardless operator experience. In addition, the beneficial effects of IVUS were remarkable when complex PCI was guided by less experience operators.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Prognostic Impact of Operator Experience and IVUS Guidance on Long-Term Clinical Outcomes After Complex PCI.

Reference: Ki Hong Choi, MD, PHD et al J Am Coll Cardiol Intv 2023;16:1746–1758.


Subscreva-se a nossa newsletter semanal

Receba resumos com os últimos artigos científicos

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...